One of the many ways in which the web differs from conventional media is the potential difficulty of assessing the financial interests of those who promote a site. This week the BMJ reports how a manufacturer of interferon beta is trying to encourage patients with multiple sclerosis to lobby the National Institute for Clinical Excellence (NICE) …